Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 17 January 2024 on Women’s Health Strategy update, HCWS192, whether the National Institute for Health and Care Research challenge fund will fund research into anti-epilepsy medicines safe for use in pregnancy.

The Department commissions research through the National Institute for Health and Care Research (NIHR). In the Written Statement of 17 January 2024, the NIHR announced plans for a £50 million NIHR Challenge to tackle disparities within maternity. This initiative is a new five-year investment allocated from within NIHR’s research budget. This funding is additional to the £53 million that the NIHR spent between April 2022 and July 2023 into research programmes to support women’s sexual and reproductive health, with further funding for wider health and care research that benefits women.

The specific focus of this work is being developed and we expect that the NIHR will launch a call for applications in spring 2024. Further information will be available on the NIHR website in due course. The NIHR welcomes funding applications for research into any aspect of human health, including anti-epilepsy medicines safe for use in pregnancy.